Skip to content

Clinical trials

Burkitt Lymphoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Country / region: Japan Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20192
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca2
Amgen1
Institut de Recherches Internationales Servier1
Jichi Medical University1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma10
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Lymphoma, B-Cell3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Recurrence3
Lymphoma, Follicular2
Immune System Diseases1
Leukemia1
Lymphoma1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.